Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Deoxycorticosterone acetate (Cortexone acetate) 是肾上腺产生的类固醇激素,具有盐皮质激素活性,并作为醛固酮的前体。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 253 | 现货 | ||
100 mg | ¥ 418 | 现货 | ||
500 mg | ¥ 997 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 385 | 现货 |
产品描述 | Deoxycorticosterone acetate (Cortexone acetate) is the 21-acetate derivative of desoxycorticosterone, used for intramuscular injection for replacement therapy of the adrenocortical steroid. |
激酶实验 | Kinase inhibition: The ability of compounds to inhibit ATR, ATM or DNAPK kinase activity istested using a radiometric-phosphate incorporation assay. A stock solution isprepared consisting of the appropriate buffer, kinase, and target peptide. To this isadded the compound of interest, at varying concentrations in DMSO to a final DMSO concentration of 7%. Assays are initiated by addition of an appropriate [γ-33P]ATP solution and incubated at 25 ℃. Assays are stopped, after the desired time course, by addition of phosphoric acid and ATP to a final concentration of 100 mM and 0.66 μM, respectively. Peptides are captured on a phosphocellulose membrane, prepared as per manufacturer's instructions, and washed six times with 200 μL of 100 mM phosphoric acid, prior to the addition of 100 μL of scintillation cocktail and scintillation counting on a 1450 Microbeta Liquid Scintillation Counter. Dose?response data are analyzed using GraphPad Prism software |
别名 | 醋酸去氧皮质酮, DOC acetate, Cortexone acetate, 11-Deoxycorticosterone acetate, 醋酸脱氧皮质酮 |
分子量 | 372.5 |
分子式 | C23H32O4 |
CAS No. | 56-47-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9 mg/mL (24.2 mM)
Ethanol: 6 mg/mL (16.1 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.6846 mL | 13.4228 mL | 26.8456 mL | 67.1141 mL |
5 mM | 0.5369 mL | 2.6846 mL | 5.3691 mL | 13.4228 mL | |
10 mM | 0.2685 mL | 1.3423 mL | 2.6846 mL | 6.7114 mL | |
DMSO | 20 mM | 0.1342 mL | 0.6711 mL | 1.3423 mL | 3.3557 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Deoxycorticosterone acetate 56-47-3 Endocrinology/Hormones GPCR/G Protein Metabolism Neuroscience Glucocorticoid Receptor Endogenous Metabolite Adrenergic Receptor Deoxycorticosterone 11-Deoxycorticosterone Acetate Inhibitor Cortexone Acetate renal inflammation Deoxycorticosterone Acetate 醋酸去氧皮质酮 adrenocortin unilateral nephrectomy DOC Mineralocorticoid Receptor DOC Acetate 11-Deoxycorticosterone fibrosis DOC acetate Cortexone acetate Cortexone aldosterone precursor glomerular injury and proteinuria 11-Deoxycorticosterone acetate 醋酸脱氧皮质酮 inhibit inhibitor